Read More Pharma Industry News Neurizon Therapeutics (ASX: NUZ) NUZ-001 activates dual protein clearance pathways in ALS neuronal study Neurizon Therapeutics NUZ-001 activates two protein clearance pathways in ALS neurons. Read what the preclinical data means ahead of the HEALEY trial. byVenkateshApril 1, 2026